Chinese Regulators Block SoftBank's $5.4 Billion Acquisition of ABB's Robotics Division
nashnova research
China's top planning agency has formally blocked SoftBank's $5.4 billion bid for ABB's robotics division — a decision that knocks out the centrepiece of Masayoshi Son's 'physical AI' strategy and leaves a major gap in SoftBank's broader AI roadmap.
Why was the deal suddenly blocked?
The National Development and Reform Commission (NDRC) — China's lead agency for supply-chain security — formally told SoftBank the deal will not be allowed to proceed.
As recently as last week, SoftBank and people familiar with the NDRC review still expected the deal to be approved. The reversal caught all sides off guard.
This means → the block was not a gradual tightening of terms but a late-stage U-turn. SoftBank is now trying to understand what went wrong and whether a fresh application is possible.
What exactly is Beijing worried about?
ABB's robotics unit has a massive China footprint: over 90% of robots serving Chinese customers are manufactured locally, and the division employs roughly 12,700 people in China. That presence is both the deal's main attraction and its regulatory flash point.
The NDRC's concerns centre on three issues: ① supply-chain migration out of China ② loss of local manufacturing capacity ③ robotics operational data being transferred offshore and used to train AI models — including those built by OpenAI, in which SoftBank is a major investor.
In plain terms = Beijing fears that once the factories and data belong to SoftBank, China could lose both industrial-robot manufacturing capacity and data sovereignty in one stroke.
Did regulators offer any compromise?
People briefed on the review say the NDRC explored several middle-ground options: keeping some intellectual property in China, and potentially requiring parts of the business to be divested to a Chinese owner as a precondition for approval.
Yet days before the block, SoftBank still had significant uncertainty about what conditions China was formally demanding.
This reflects a broader reality: with Sino-Japanese ties under strain and US-China strategic competition intensifying, cross-border deal approvals have become deeply unpredictable. The deal cleared China's competition review in February but was ultimately stopped at the foreign-investment security review stage.
What does this mean for SoftBank?
ABB's robotics division was the anchor asset in Son's "physical AI" strategy, intended to form a business foundation alongside US AI and robotics firm Roze. With the acquisition blocked, that roadmap has a major gap.
Son is also in talks to acquire Allied Universal, the world's largest private security group, aiming to upgrade its operations with robotics and AI — but without the robotics base asset, the broader thesis loses credibility.
SoftBank shares have fallen 38% over the past month and 28% over the past year, weighed down by concerns over AI demand and OpenAI's delayed IPO.
Is there any path forward?
SoftBank is assessing whether it can reapply under revised terms, but there is no public signal that the NDRC is willing to reopen talks.
OpenAI's IPO delay is also pressuring the listing plans of SoftBank's US data-centre developer SB Energy, which targets a $50 billion valuation.
This means → whether Son's physical-AI strategy can proceed on its original path depends entirely on whether this deal can be revived — and that answer is, for now, completely unresolved.
市场有风险，内容仅供研究参考，不构成投资建议。